- Home
- GHG vs INBX Comparison
GHG vs INBX Comparison
Compare GHG & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- INBX
- Stock Information
- Founded
- GHG 2004
- INBX 2010
- Country
- GHG China
- INBX United States
- Employees
- GHG N/A
- INBX N/A
- Industry
- GHG Hotels/Resorts
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- GHG Consumer Discretionary
- INBX Health Care
- Exchange
- GHG Nasdaq
- INBX Nasdaq
- Market Cap
- GHG 255.9M
- INBX 237.5M
- IPO Year
- GHG 2018
- INBX 2020
- Fundamental
- Price
- GHG $3.15
- INBX $14.76
- Analyst Decision
- GHG
- INBX Hold
- Analyst Count
- GHG 0
- INBX 1
- Target Price
- GHG N/A
- INBX N/A
- AVG Volume (30 Days)
- GHG 23.3K
- INBX 115.9K
- Earning Date
- GHG 11-25-2024
- INBX 08-13-2024
- Dividend Yield
- GHG 3.19%
- INBX N/A
- EPS Growth
- GHG 69.37
- INBX N/A
- EPS
- GHG 0.34
- INBX 118.83
- Revenue
- GHG $208,477,725.00
- INBX $1,687,000.00
- Revenue This Year
- GHG N/A
- INBX N/A
- Revenue Next Year
- GHG $8.78
- INBX N/A
- P/E Ratio
- GHG $9.31
- INBX $0.13
- Revenue Growth
- GHG 48.19
- INBX 24.26
- 52 Week Low
- GHG $2.31
- INBX $10.80
- 52 Week High
- GHG $4.61
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- GHG 63.96
- INBX 44.24
- Support Level
- GHG $3.01
- INBX $15.11
- Resistance Level
- GHG $3.32
- INBX $15.91
- Average True Range (ATR)
- GHG 0.18
- INBX 0.64
- MACD
- GHG 0.07
- INBX -0.24
- Stochastic Oscillator
- GHG 75.71
- INBX 1.62
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.